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Human T-cell leukemia virus types 1 and 2 (HTLV-1 and HTLV-2) are delta retroviruses
that share a common overall genetic organization, splicing pattern, and ability to infect
and immortalize T-cells in vitro. However, HTLV-1 and HTLV-2 exhibit a clearly distinct
pathogenic potential in infected patients. To find clues to the possible viral determinants
of the biology of these viruses, recent studies investigated the timing of expression and
the intracellular compartmentalization of viral transcripts in ex-vivo samples from infected
patients. Results of these studies revealed a common overall pattern of expression
of HTLV-1 and -2 with a two-phase kinetics of expression and a nuclear accumulation
of minus-strand transcripts. Studies in cells transfected with HTLV-1 molecular clones
demonstrated the strict Rex-dependency of this “two-phase” kinetics. These studies
also highlighted interesting differences in the relative abundance of transcripts encoding
the Tax and Rex regulatory proteins, and that of the accessory proteins controlling Rex
expression and function, thus suggesting a potential basis for the different pathobiology
of the two viruses.
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INTRODUCTION
Human T-cell leukemia virus types 1 and 2 (HTLV-1 and
HTLV-2) are genetically related deltaretroviruses (Lairmore
and Franchini, 2007). Although both viruses immortalize T-
cells in culture and establish a persistent infection in vivo
(Matsuoka and Jeang, 2007), they differ substantially in
terms of pathogenic potential. Unlike HTLV-1, which causes
adult T-cell leukemia/lymphoma (ATLL) and tropical spastic
paraparesis/HTLV-1-associated myelopathy (TSP/HAM), HTLV-
2 has not been linked to lymphoidmalignancies. However, HTLV-
2 infection is associated with an increase in lymphocytes counts
(Bartman et al., 2008) and coinfection with HTLV-2 plays an
important role in the progression of HIV-infected patients to
AIDS (Casoli et al., 2007).
The two viruses present similar genetic organization and
expression strategies (Ciminale et al., 1992, 1995; Koralnik et al.,
1992; Cavallari et al., 2011) and share an average 65% identity at
the nucleotide level, with higher conservation in the gag, pol, env,
and tax/rex genes and lower in the long terminal repeats (LTR),
protease and proximal pX region.
The coding potential of the HTLV genomes is greatly enhanced
by several gene expression strategies that include ribosomal
frameshifting (which generates a Gag-Pro-Pol polyprotein) and
alternative splicing (which produces distinct mRNAs coding for
Env and non-structural proteins coded by the X region). The pX
regions of HTLV-1 and HTLV-2 contain, respectively, four and
five major open reading frames (ORFs), termed x-I through x-
V. The x-III and x-IV ORFs code for Rex and Tax, which are
produced from a dicistronic doubly-spliced mRNA containing
exons 1, 2, and 3. Tax and Rex play a critical role in regulating
viral expression at the transcriptional and post-translational lev-
els, respectively. Other transcripts produced by the X region code
for accessory proteins; these transcripts include singly-spliced
mRNAs coding for p21rex, p12, and p13 (HTLV-1), truncated
isoforms of Rex (tRex) and p28 (HTLV-2) and doubly-spliced
mRNAs coding for p30/tof (HTLV-1), p10 and p11 (HTLV-2)
(Ciminale et al., 1992, 1995; Koralnik et al., 1992). While most
of the regulatory and accessory proteins of the two viruses share
structural and functional homologies, p13 and p8 appear to be
unique to HTLV-1 and p11 is unique to HTLV-2. p13 corresponds
to the C-terminal 87 amino acids of p30/tof (Koralnik et al., 1992)
and is localized mainly in the mitochondrial inner membrane
(Ciminale et al., 1999) although it can be partly localized to the
nucleus especially when expressed at high levels and in conjunc-
tion with Tax (Andresen et al., 2011). p13 increases mitochondrial
permeability to K+ and activates the electron transport chain,
resulting in an increased production of mitochondrial reactive
oxygen species (ROS) (Silic-Benussi et al., 2009). Increased ROS
affect both cell survival and proliferation depending on the cell’s
inherent ROS set-point. Results of our studies indicated that p13
expression leads to in mitogenic activation of normal resting T-
cells, which have low ROS levels; in contrast, p13 induces cell
death in cancer cells which are characterized by a high ROS
setpoint (Silic-Benussi et al., 2010a,b). p8, which is a cleaved
form of p12, traffics to the immunological synapse and favors
T-cell anergy. p8 also increases cell-to-cell viral transmission
through the formation of intercellular conduits among T-cells
(Van Prooyen et al., 2010a,b). p11, which is unique to HTLV-2,
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exhibits a partial functional homology to HTLV-1 p12, in that it
is able to bind the MHC heavy chain (Johnson et al., 2000).
Recent studies showed that both HTLV-1 and HTLV-2 also
produce complementary-strand mRNAs that are transcribed
from promoters in the 3′ LTR; these genes were termed, respec-
tively, HBZ (HTLV-1 bZIP factor) (Gaudray et al., 2002) and
APH2 (anti-sense protein of HTLV-2) (Halin et al., 2009). HTLV-
1 generates two major minus-strand transcripts, one spliced (hbz
sp1) and the other unspliced (hbz us) (Cavanagh et al., 2006;
Murata et al., 2006; Satou et al., 2006), translated in two proteins
that differ by 7 amino acids at their N-terminus (Murata et al.,
2006). The negative strand of HTLV-2 generates only one spliced
transcript that codes for the APH2 protein (Halin et al., 2009).
Both HBZ and APH2 interact with CREB, resulting in the inhi-
bition of Tax-mediated transcription from the 5′LTR (Gaudray
et al., 2002; Halin et al., 2009); however, while the hbz mRNA has
a growth-promoting effect on T-cells (Satou et al., 2006), no func-
tion has been described for the aph2 mRNA. Interestingly, the
hbz and aph2 transcripts were detected mainly in the nucleus of
infected cells (Rende et al., 2011; Bender et al., 2012), supporting
the notion of their possible role as non-coding RNAs.
TEMPORAL ANALYSIS OF HTLV-1 EXPRESSION
An early study by Hidaka et al. (Hidaka et al., 1988) estab-
lished that HTLV-1 expression is controlled by two key regulatory
circuits: a positive feedback provided by the viral transactiva-
tor Tax, which drives transcription of the viral genome, and
a post-transcriptional regulatory loop provided by Rex, which
binds to the Rex-responsive element (RXRE) present at the 3′
end of HTLV-1 transcripts and enhances the nuclear export and
expression of a subset of mRNAs coding for the virion-associated
proteins Gag-Pol and Env. This study was conducted by trans-
fecting wild type and Rex-mutant proviral clones in fibroblast cell
lines followed by isolation of nuclear and cytoplasmic mRNAs
and analysis by Northern Blot, a technique that was not capa-
ble of distinguishing among different mRNAs of similar size.
This approach revealed three major size classes of polyadenylated
mRNAs: (i) the 9-kb genomic mRNA coding for Gag-Pro-Pol,
(ii) the 4-kb singly spliced mRNA coding for the envelope gly-
coproteins, (iii) mRNAs of approximately 2.1 kb coding for Tax
and Rex (Hidaka et al., 1988). The study did not consider other
spliced mRNAs coding for the accessory proteins, as those were
discovered several years later. The authors also observed a distinct
timing of expression of the transcripts, with the 2.1 kb mRNA
preceding the expression of the 9- and 4-kb transcripts, while
at a later stage only a trace of the 2.1 kb mRNA, was detectable.
Interestingly, a Rex-defective proviral clone only expressed the
2.1 kb mRNAs, demonstrating that Rex is essential for gag and
env (but not tax/rex) expression.
A subsequent study by Kimata and Ratner (1991) investigated
the temporal regulation of HTLV-1 expression following infec-
tion of primary lymphocytes by co-cultivation with the lethally-
irradiated HTLV-1-infected cell line MT2. Viral transcripts were
detected by RT-PCR using primers spanning the splice-junctions
of known viral mRNAs (gag, env, tax/rex). Results showed that
tax/rex mRNA appeared at day 4 of co-cultivation, the env mRNA
at day 25, and the gag–pol mRNA at day 100 of co-cultivation.
The expression of viral transcripts were monitored for 150 days
post-infection.
With the aim of investigating the timing of expression of all
the transcripts encoded by HTLV-1, Li et al. employed RT-PCR
and both an in vitro model and a rabbit animal model of HTLV-1
infection (Li et al., 2009). Results showed a general trend toward
increased viral gene expression over time both in vitro and in vivo.
However, these studies did not reveal a clear temporal separation
between early and late viral transcripts or a switch in the expres-
sion of early vs. late viral transcripts as suggested by Hidaka et al.
(1988).
To gain further insight into these aspects of HTLV-1 regula-
tion, we recently investigated the timing of spontaneous onset
of HTLV-1 expression in vitro in primary cells obtained from
infected individuals, and measured the levels of individual tran-
scripts by real-time RT-PCR (qRT-PCR) using splice site-specific
primers, which allowed measurements of the levels of individ-
ual alternatively spliced transcripts. qRT-PCR analysis was also
carried out in cells transfected with wild type and Rex-knockout
HTLV-1-molecular clones.
We first employed an ex vivo viral reactivation model based
on the depletion of CD8+ cytotoxic T cells from peripheral
blood mononuclear cells (PBMC) of HTLV-1-infected patients,
which results in a sharp rise in viral expression (Hanon et al.,
2000). Results obtained for 6 TSP/HAM and 3 ATLL patients
revealed that the most abundant plus-strand transcripts were
tax/rex, gag, and env, followed by p21rex, p30tof, p13, and p12
mRNAs; minus-strand HBZ transcripts were expressed at high
levels (Rende et al., 2011).
These studies also revealed a sharp upregulation of viral
expression upon ex vivo culture which is shown in Figure 1, where
the time course of expression of all plus-strand viral mRNAs
(NCN, Normalized Copy Number) is compared to the NCN of
all negative-strand mRNAs (hbz sp1 and us). Results of this anal-
ysis in samples examined from the 9 patients revealed 3 main
patterns (Figure 1). The minus-strand transcripts were slightly
up-regulated and their overall NCN values were very similar
among the different patients. In contrast, the up-regulation of
plus-strand transcripts was more evident and the expression
levels of plus-strand transcripts were highly variable in these
patients. Patient TSP-4 shows an overall expression of plus-
strand NCN of about 2 orders of magnitude greater than TSP1,
instead ATLL-3 patient showed a peculiar pattern of expression,
with a marked prevalence of minus-strand transcripts compared
to plus-strand transcripts (only tax/rex, gag, and env mRNAs
were detectable). This patient, whose PBMCs were dominated by
monoclonal leukemic cells, might thus represent an example of
the subset of ATLL cases in which plus-strand transcription is
inhibited by genetic or epigenetic mechanisms (Taniguchi et al.,
2005).
The graphs in Figure 2 illustrate the prevailing pattern of the
kinetics of expression of individual HTLV-1 mRNAs revealed by
these studies. Tax/rex was the earliest transcript in all patients and
p21rex also showed an early peak of expression in the majority
of the patients; env, gag, p13, p30tof, and hbz mRNAs revealed a
late peak of expression in the majority of the cases. Instead, p12
showed a very variable pattern of expression in the patients. This
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FIGURE 1 | Normalized Copy Number (NCN) of the sum of all plus-strand viral mRNAs (red lines) and of the minus-strand mRNAs, (hbz sp1 and us)
(black lines) in PBMCs from 3 infected patients (TSP-1, TSP-4, ATLL-3) over a 48-h time course of culture in vitro.
distinct temporal expression pattern is consistent with the tax/rex
mRNA acting as an “early” master gene that drives the expression
of the other viral transcripts (Rende et al., 2011). Nevertheless,
this early-late switch in viral expression is apparently absent in
the ATLL-3 patient, while it was evident in all the other patients
examined.
This study also tested the HTLV-1 mRNA expression using an
in vitro model based on the transfection of full-length HTLV-
1 molecular clones, which made it possible to investigate the
nucleo-cytoplasmic partition of the different transcripts during
the time course of expression and to assess the effects of Rex
on these processes. Consistent with the results obtained from
patient PBMCs, transfection of wild-type HTLV-1 resulted in an
“early” nucleo-cytoplasmic export of tax/rex followed by a rise in
the export of gag and env mRNAs. Interestingly, this two-phase
kinetics was not observed upon transfection of a REX-KOHTLV-
1 molecular clone, demonstrating the strict Rex-dependency of
this “two-phase” kinetics of expression (Rende et al., 2011). The
early expression timing of tax/rex suggests that expression of this
transcript is independent of Rex. However, two studies based on
the expression of intronless cDNAs derived from the full-length
HTLV-1 mature transcripts indicated that Rex may enhance the
expression of the tax/rex RNA (D’Agostino et al., 1999; Bai et al.,
2012) and binds the RXRE in the context of this transcript
(Bai et al., 2012). These apparently conflicting results suggest
that the impact of Rex is highly dependent on the processing
pathway of the transcripts. It is thus possible that routing the tran-
scripts through the splicing machinery might result in increased
efficiency of expression even in the absence of Rex.
TEMPORAL ANALYSIS OF HTLV-2 EXPRESSION
Like HTLV-1, HTLV-2 produces plus- and minus-strand alter-
natively spliced transcripts that code for virion components
and non-structural proteins, including Tax, Rex, and the acces-
sory proteins (Feuer and Green, 2005; Younis and Green,
2005).
The kinetics of expression of the individual HTLV-2 tran-
scripts were described for the first time by Bender et al. (2012).
In this paper, the authors investigated the expression kinetics
of HTLV-2 mRNAs in a chronically infected cell line and in
PBMCs obtained from 3 infected patients using splice site-
specific primers and qRT-PCR. The three patients analyzed had
similar proviral loads and were HTLV-1- and HIV-1-negative
(Bender et al., 2012).
Upon ex vivo culture of PBMC the expression of plus-strand
transcripts was sharply upregulated in all the examined patients,
although the overall expression levels at time zero were highly
variable, with patient A showing much lower levels of expression
compared to patients B and C (Figure 3). On the other hand,
the minus-strand transcript (APH2) was transiently upregu-
lated in patient A, not significantly changed in patient B and
strongly downregulated (>20-fold) in patient C, who exhibited
the highest levels of plus-strand mRNAs expression. The patients
thus showed an apparent inverse correlation between changes in
minus-strand expression and levels of expression of plus-strand
transcripts (Figure 3).
Figure 4 shows a synoptic representation of the kinetics of
expression of HTLV-2 mRNAs. Patients A and B showed a two-
phase kinetics of HTLV-2 gene expression, with an early sharp rise
in tax/rex(1-2-3) expression followed by a later expression of gag,
env(1-2iso), p28/tRex(1-3), and 1-2-B. One of the two patients
also expressed p28/tRex(1-B) as an early transcript, although at
a level 1000-fold lower than the “late” 1-3 transcript that also
encodes p28 and tRex (Bender et al., 2012). Patient C showed a
peculiar kinetics of expression with the APH2 expressed only at
the beginning of the time-course followed by a sharp downregu-
lation, while tax/rex(1-2-3), gag, env(1-2iso), and p28/tRex(1-3)
were expressed as later transcripts. The p11/p10(1-2-A) mRNA
was below the threshold of detection in all patients, suggest-
ing that these proteins might play a marginal role, at least in
the context of the infected cells circulating in the peripheral
blood.
To verify these findings, we employed an in vitro model in
which viral expression in the BJAB-Gu HTLV infected cell line
was synchronized by controlling the conditions of in vitro culture.
Diluting a culture of confluent cells, resulted in an overall upreg-
ulation of viral gene expression. Results of qRT-PCR confirmed
the 2-phase kinetics with the expression of the tax/rex(1-2-3),
p28/tRex(1-B), and 1-2-B preceding that of the gag/pol, env, and
p28/tRex(1-3) mRNAs.
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FIGURE 2 | Genetic organization, splicing pattern and kinetics of
expression of HTLV-1 mRNAs. On the left, structure and coding
potential of HTLV-1 alternatively spliced mRNAs are shown. ORFs are
indicated by boxes. Splice sites are indicated by numbers. Right-hand
graphs show schematic representations of the prevalent kinetics of
expression of HTLV-1 mRNAs in different patients. The p12 mRNA did
not show a consistent pattern of expression among the different
patients (n.c.).
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FIGURE 3 | Normalized Copy Number (NCN) of the sum of all plus-strand viral mRNAs (red line) and of the minus-strand mRNA, aph2 (black line) in
PBMCs from 3 HTLV-2-infected patients (A,B and C) in a 48-h time course of culture in vitro.
MOLECULAR BASIS FOR THE 2-PHASE KINETICS AND
REGULATION OF REX FUNCTION BY VIRAL PROTEINS
To find clues to the possible regulatory mechanism underlying
the 2-phase kinetics of HTLV-1 expression, we used the expres-
sion data to generate a mathematical model (Corradin et al.,
2011; Rende et al., 2011). Results underscored the importance
of a delay in Rex function compared with Tax in the observed
expression kinetics. These considerations led us to investigate
the time course of Tax and Rex protein expression from the
ACH full-length infectious molecular clone and from a plasmid
coding for the mature tax/rex mRNA. Flow cytometry analy-
ses showed a relative accumulation of Rex at later time points;
consistent with this finding, Rex revealed a slower rate of degrada-
tion compared with Tax, suggesting that the activity of these two
regulatory proteins might be controlled at the post-translational
level. Similar experiments have not yet been carried out for
HTLV-2.
A further layer of complexity of the HTLV regulatory networks
is revealed by experimental evidence indicating that the function
of Rex might be controlled by virus-encoded inhibitors. Among
these, truncated forms of Rex lacking the N-terminal, RXRE-
binding domain are produced by singly spliced transcripts both
in HTLV-1 andHTLV-2 (Ciminale et al., 1996; Heger et al., 1999).
These truncated Rex isoform are termed p21Rex (HTLV-1) and
tRex (HTLV-2). tRex proteins contain the activation and mul-
timerization domains of full-length Rex and act as inhibitors of
full-length Rex-2 (Ciminale et al., 1997), while p21 Rex contains
the activation but not the multimerization domains of Rex and
its function as a repressor of the full length protein is controver-
sial; some reports suggest that it inhibits Rex (Heger et al., 1999)
whereas others do not (Ciminale et al., 1997; Bai et al., 2012).
The x-II ORF products of HTLV-1 (p30/tof) and HTLV-2
(p28) were shown to inhibit both the tax/rex mRNA and the Rex
protein (Nicot et al., 2005) (see also the paper by Anupam at al.
in this issue).
Interestingly, the relative expression of the tax/rex mRNA com-
pared to the mRNAs coding for potential inhibitors of Tax (p30tof
and p28) and Rex (p21rex and tRex) appears to be skewed toward
tax/rex in HTLV-1 and toward the inhibitors in HTLV-2 (Rende
et al., 2011; Bender et al., 2012). Furthermore, the main trex
mRNA was expressed as a “late” transcript in HTLV-2 infected
individuals while the mRNA coding for its HTLV-1 ortholog
(p21rex) was expressed early in most HTLV-1 infected patients.
These findings support the idea that complex feedback regulatory
loops control HTLV expression at the post-transcriptional level
and suggesting interesting differences in the fine-tuning of Rex
function between the two viruses.
Future studies should be aimed at further investigating the
functions of these regulatory proteins in HTLV-1 and HTLV-2
and at understanding how they may contribute to the different
pathobiology of the two viruses.
CONCLUSIONS AND PERSPECTIVES
The temporal regulation of viral expression has been thoroughly
characterized in DNA tumor viruses such as herpes viruses, where
different patterns of viral gene expression are associated with
latent or productive phases of the viral life cycle and with different
diseases [reviewed in Young and Rickinson (2004)]. In the case
of EBV, the switch between early and late viral genes is achieved
mainly through the genetic and epigenetic regulation of alterna-
tive viral promoters. Human papillomaviruses (HPV) exploit a
combination of alternative promoter usage, alternative splicing
and selection of “early” vs. “late” polyadenylation sites [reviewed
in Schwartz (2008)]. The early/late pattern of HPV expression is
associated with tissue tropism and restriction of the lytic cycle to
differentiated epithelia (Moody and Laimins, 2010).
HTLV-1 and HTLV-2 encode structural, regulatory, and acces-
sory genes from several alternatively spliced mRNAs generated
both from the 5′ LTR and 3′ LTR promoters. This complex expres-
sion pattern is regulated by two key feedback loops mediated
by the two regulatory proteins Tax and Rex which produce a
two-phase kinetics in both viruses.
The fact that both HTLV-1 and HTLV-2 show an overall simi-
lar two-phase kinetics of expression suggests that this converging
expression strategy might reflect important in vivo constraints for
long term persistence in T-cells and evasion from the immune
response which characterize these viruses. On the other hand
we also observed some peculiar differences between HTLV-1
and HTLV-2 gene expression, especially concerning the relative
expression and timing of the mRNAs coding for proteins that
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FIGURE 4 | Genetic organization, splicing pattern and kinetics of
expression of HTLV-2 mRNAs. The structure and coding potential
of HTLV-2 alternatively spliced mRNAs are shown on the left. ORFs
are indicated by boxes. Splice sites are indicated by numbers. The
graphs depict the prevalent kinetics of expression of HTLV-2 mRNAs
in different patients. n.c. indicates transcripts that did not show a
consistent pattern of expression in different patients. n.d.: not
determined.
control Rex expression and function (see above). These differ-
ences might provide the molecular basis for the different tropism
and pathogenicity of the two viruses.
However, in contrast to the other tumor viruses mentioned
above, neither the levels or the timing of expression of differ-
ent genes has been linked to a different disease outcome, a topic
that should be addressed in future studies. In addition, both the
“latent” expression detected in peripheral blood HTLV-infected
cells and the “reactivation” upon culture in vitro are, at present,
poorly understood phenomena. Further investigations are needed
to define the pattern (and levels) of HTLV expression in different
lymphoid organs.
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Interestingly, also in the case of HIV-1, another complex
human retrovirus, viral gene expression is controlled by two
key regulatory proteins Tat and Rev, which control, respectively,
transcription and post-transcriptional processing of alternatively-
spliced viral mRNAs.
Early studies suggest that the HIV-1 life cycle is also character-
ized by a two-phase kinetics with Tat, Rev, and Nef expressed as
early genes and Env, Vpu, Vif, Vpr, Gag, Pro, and Pol expressed
as late genes. In the context of this expression strategy, Rev acts as
a molecular switch controlling the transition between latent and
productive infection (Ahmad et al., 1989; Kim et al., 1989). The
two-phase kinetics was confirmed by Davis et al. (Davis et al.,
1997), using cell-free HIV infection of Hut-78 cells. Using RT-
PCR the authors observed the appearance of the tat, rev and nef
mRNAs in the cytoplasm 12–16 h after infection, while env and
gag expression reached its maximum between 20 and 24 h after
infection. In contrast, cell-to-cell transmission of HIV-1 resulted
in a late marked increase of env and gag mRNAs without a
preceding peak of tat, rev and nef mRNAs.
However, to date, the relative abundance and the time course
of expression has not been measured at a single transcript level
using qRT-PCR like in the case of HTLV-1 and HTLV-2.
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